Five misunderstandings about Blood Pressure that you should not believe
It is very important to maintain blood pressure numbers to keep our body in balanced condition. If you are a health freak, here are...
Bharat Biotech’s Odisha facility to make 10 types of vaccines including for Covid-19, Malaria
Bharat Biotech International Ltd (BBIL), a Hyderabad based pharma major, has said it would manufacture 10 types of vaccines. These would be produced in...
OncoSec announces first subjects dosed in Phase 1 trial of COVID-19 vaccine candidate
OncoSec Medical Inc has announced that it has dosed several subjects in its Phase 1 clinical trial of CORVax12.
According to the company, it is...
Glenmark Pharmaceuticals gets approvals from USFDA for generic Prograf capsules
Glenmark Pharmaceuticals Inc., USA has received final approval by the United States Food & Drug Administration (USFDA) for Tacrolimus Capsules USP, 0.5 mg, 1...
FlowMetric introduces ‘breakthrough’ Covid-19 antibody test
FlowMetric has launched a 'powerful advancement' in Covid-19 antibody testing that the company said delivers exceptional performance compared to existing tests on the global...
Bharat Biotech raises hopes to chase away Covid-19 as it commences Covaxin’s Phase III...
Hyderabad-based Bharat Biotech has said it has commenced Phase III trials of COVAXIN™ today (November 17, 2020).
According to the company, this exercise, conducted in...
Humanigen announces positive interim Phase 3 Data of Lenzilumab in Covid patients
Humanigen Inc has announced positive interim Phase 3 data of lenzilumab in patients hospitalized with Covid-19.
Humanigen is a clinical stage biopharmaceutical company focused on...
Lilly’s Bamlanivimab to be used as Covid-19 treatment
Bamlanivimab (LY-CoV555), a neutralising antibody emerged from collaboration between Lilly and Vancouver-based AbCellera, has been given authorisation by Health Canada, under the Interim Order...
BAT moves Covid candidate vaccine towards Phase I human clinical trials
BAT has announced plans to commence a Phase I first-time-in-human study of its Covid-19 vaccine candidate.
The announcement by BAT's US Bio-tech arm, Kentucky BioProcessing...
LumiraDx gets approval for its COVID-19 Antigen Test in India
Diagnostics testing company LumiraDx has received emergency use approval by India's Central Drugs Standard Control Organisation for its SARS-CoV-2 Antigen test for use in...
